Home > Insider Trading > Filing (0000899243-22-024034)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1880438	An2 Therapeutics Inc.	ANTX	()	E9

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1783165	Adjuvant Global Health Technology Fund, L.p.	C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017	No	No	Yes	No
1799812	Adjuvant Global Health Technology Fund De, L.p.	C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017	No	No	Yes	No
1935084	Adjuvant Capital Management, Llc	C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017	No	No	Yes	No
1935100	Adjuvant Capital Gp, L.p.	C/O Adjuvant Capital, L.p. 501 Fifth Avenue, Suite 1404 New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-29	1,651,636	$0.00	1,651,636	No	4	C	Direct
Common Stock	Acquisiton	2022-03-29	312,415	$0.00	312,415	No	4	C	Indirect	By Adjuvant Global Health Technology Fund DE, L.P.
Common Stock	Acquisiton	2022-03-29	392,433	$0.00	2,044,069	No	4	C	Direct
Common Stock	Acquisiton	2022-03-29	74,230	$0.00	386,645	No	4	C	Indirect	By Adjuvant Global Health Technology Fund DE, L.P.
Common Stock	Acquisiton	2022-03-29	166,666	$15.00	2,210,735	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	C	Indirect	By Adjuvant Global Health Technology Fund DE, L.P.
No	4	C	Direct
No	4	C	Indirect	By Adjuvant Global Health Technology Fund DE, L.P.
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2022-03-29	1,651,636	$0.00	1,651,636	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2022-03-29	312,415	$0.00	312,415	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2022-03-29	392,433	$0.00	392,433	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2022-03-29	74,230	$0.00	74,230	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Indirect
No	4	C	Direct
No	4	C	Indirect

Footnotes

Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.